Novartis ag stock2/13/2024 ![]() Sandoz is the world's largest generics and biosimilars company, and now, by becoming an independent company, we can focus on how we grow that business, how we bring more products to patients, and really continue to build on the momentum that we've created over the last couple of years," Saynor told CNBC on Wednesday. Sandoz CEO Richard Saynor also on Wednesday told CNBC that the spinoff would help his company focus its own strategy, which includes a pipeline of 25 biologics projects, with five more set to launch over the next two years. Jefferies analysts have valued the Sandoz listing at between $12.3 billion and $16.2 billion, when the company begins trading on Wednesday. "With several consecutive quarters of sales growth, Sandoz starts out from a position of strength as a global leader in Generics and Biosimilars, and I am confident they are poised to deepen their impact on patients and society," he added. Year-over-year quarterly sales growth most recently was 12.1. Novartis AG (ADR)’s trailing 12-month revenue is 47.9 billion with a 18.1 net profit margin. ![]() Currently, Novartis AG (ADR)’s price-earnings ratio is 27.2. ![]() NVS's next ex-dividend date has not been announced yet. Novartis AG (ADR)’s stock is NA in 2023, NA in the previous five trading days and up 11.72 in the past year. In a statement alongside the Wednesday announcement, Narasimhan said this was a "truly historic moment for Novartis and Sandoz" as they begin life as independent companies. Novartis shareholders who own NVS stock before this date received Novartis's last dividend payment of 5.34 per share on Oct 03, 2023. Novartis also reiterated its full-year guidance, with sales expected to grow in a high single-digit percentage and with core operating income set to grow in the low double digits to mid-teens. Personal Loans for 670 Credit Score or Lower Personal Loans for 580 Credit Score or Lower Best Debt Consolidation Loans for Bad Credit Find the latest dividend history for Novartis AG Common Stock (NVS) at.
0 Comments
Leave a Reply.AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |